PDF summary
return to news

NEW YORK | June 2015

Praesidian Capital Successsfully Exits $11.5 Million Debt Investment in metanexgen

Exit Coincides with Company�s Acquisition by Insignia Capital Group

NEW YORK — June 23, 2015 — Praesidian Capital (�Praesidian� or �the Firm�), a leading provider of mezzanine capital for small and mid-sized companies, confirmed today that it has exited successfully its $11.5 million subordinated debt investment in metanexgen, a provider of technology-enabled multichannel marketing solutions for the pharmaceutical and healthcare industry. Praesidian�s exit was in concert with DFW Capital Partners sale of the business to Insignia Capital Group.

Praesidian made its first investment in metanexgen�s predecessor company, Meta Pharmaceutical Services, LLC, in 2010 when it was acquired by DFW. Praesidian made a subsequent investment in 2013 when Meta acquired NexGen RxMarketing, LLC and rebranded the combined company metanexgen.

�The support we have had from Praesidian in the past five years has allowed our company to expand and evolve,� stated Brian Tilley, Partner of DFW Capital Partners. �Praesidian provided the kind of partnership that any fast-growing organization most desires and rarely finds. We are grateful to the entire Praesidian team.�

According to Glenn Harrison, Praesidian Partner, �This has been a highly successful relationship at all levels. We wish metanexgen only the best as they continue on their growth path.�

About metanexgen
Based in Bensalem, Penn., metanexgen is a provider of technology-enabled multichannel marketing solutions that allow pharmaceutical, biotechnology and medical device brands to effectively market their products to healthcare practitioners. For more information, please visit www.metanexgen.com.

About DFW Partners
DFW Capital Partners is a private equity investment firm focused on lower middle-market companies. The firm concentrates on service companies, with an emphasis on healthcare and outsourced business and industrial support services. DFW is backed by both institutional and high-net worth individual investors, and has established a 20+ year track record of success in building leading companies and delivering superior returns for its investors. DFW is headquartered in Teaneck, NJ, and maintains an office in Chevy Chase, MD. For more information contact Keith Pennell, Managing Partner, at (201) 836-6000.

About Praesidian Capital
Praesidian Capital is an innovative private investment firm focused on providing senior and subordinated debt along with growth capital to private lower middle market businesses in the United States, United Kingdom, Germany, and selectively in Northern Europe. Praesidian invests in established, small and mid-sized companies often in connection with management buyouts, recapitalizations and refinancings. Based in New York City with an office in London, Praesidian manages nearly $1 billion in committed capital. For more information, visit www.praesidian.com.

Contact: The Abernathy MacGregor Group
(213) 630-6550
Rivian Bell, rlb@abmac.com
Kristin Cole, kec@abmac.com

return to news